Literature DB >> 1416834

Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo.

M C Barc1, C Depitre, G Corthier, A Collignon, W J Su, P Bourlioux.   

Abstract

In an attempt to understand more completely why patients treated with phenothiazines (chlorpromazine and cyamemazine), methotrexate, and certain antibiotics such as clindamycin have an increased risk of developing pseudomembranous colitis, the production of toxins A and B by Clostridium difficile in the presence of these drugs was measured in vitro as well as in vivo by using axenic mice. None of the drugs tested increased the production of toxins either in vitro or in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416834      PMCID: PMC190342          DOI: 10.1128/AAC.36.6.1332

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Role of Clostridium difficile toxins in disease.

Authors:  T D Wilkins
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

2.  Stimulation of enterotoxin production of Clostridium difficile ny antibiotics.

Authors:  T Honda; I Hernadez; T Katoh; T Miwatani
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

3.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

4.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients.

Authors:  L V McFarland; C M Surawicz; W E Stamm
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

5.  [Clostridium difficile in children and adolescents undergoing anticancer and antimicrobial chemotherapy. The possibility of nosocomial acquisition].

Authors:  A Collignon; C Chaumard; I Vallet-Collomb; N Delepine
Journal:  Pathol Biol (Paris)       Date:  1988-06

6.  Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.

Authors:  S Mahe; G Corthier; F Dubos
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

7.  Inciting and etiologic agents of colitis.

Authors:  J Silva; R Fekety; C Werk; J Ebright; M Cudmore; D Batts; C Syrjamaki; J Lukens
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

8.  Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study.

Authors:  C M Surawicz; G W Elmer; P Speelman; L V McFarland; J Chinn; G van Belle
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

9.  Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes.

Authors:  C Pothoulakis; R Sullivan; D A Melnick; G Triadafilopoulos; A S Gadenne; T Meshulam; J T LaMont
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

10.  Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; N Moon; T W Chang; N Taylor; A B Onderdonk
Journal:  Gastroenterology       Date:  1978-11       Impact factor: 22.682

View more
  4 in total

Review 1.  Models for the study of Clostridium difficile infection.

Authors:  Emma L Best; Jane Freeman; Mark H Wilcox
Journal:  Gut Microbes       Date:  2012-03-01

2.  Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections.

Authors:  Kathleen M Mullane; Mark A Miller; Karl Weiss; Arnold Lentnek; Yoav Golan; Pamela S Sears; Youe-Kong Shue; Thomas J Louie; Sherwood L Gorbach
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

3.  Emerging therapies for Clostridium difficile infection - focus on fidaxomicin.

Authors:  Fredy Chaparro-Rojas; Kathleen M Mullane
Journal:  Infect Drug Resist       Date:  2013-06-28       Impact factor: 4.003

Review 4.  The Regulatory Networks That Control Clostridium difficile Toxin Synthesis.

Authors:  Isabelle Martin-Verstraete; Johann Peltier; Bruno Dupuy
Journal:  Toxins (Basel)       Date:  2016-05-14       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.